Page last updated: 2024-09-04

beta-lactams and Bacterial Infections, Gram-Negative

beta-lactams has been researched along with Bacterial Infections, Gram-Negative in 166 studies

Research

Studies (166)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (0.60)	18.7374
1990's	15 (9.04)	18.2507
2000's	57 (34.34)	29.6817
2010's	75 (45.18)	24.3611
2020's	18 (10.84)	2.80

Authors

Authors	Studies
Chinea, A; Chumbita, M; Cuesta, MA; Español Morales, I; Fernández Abellán, P; Garcia-Vidal, C; González-Sierra, P; Gudiol, C; Guerreiro, M; Lopera, C; Monzó, P; Puerta-Alcalde, P; Rojas, R; Sánchez Pina, JM; Sánchez Vadillo, I; Varela, R; Vázquez, L; Yáñez, L	1
Cabañero-Navalón, MD; Garcia-Bustos, V; Salavert Lletí, M	1
Bonomo, RA; Calvopiña, K; Dmitrienko, GI; Hinchliffe, P; Mojica, MF; Rabe, P; Schofield, CJ; Spencer, J; Vila, AJ	1
Atkinson, A; Damulira, C; Fraser, VJ; Guillamet, MCV; Kollef, MH; Micek, S	1
Bavaro, DF; Belati, A; Brindicci, G; Dalfino, L; De Gennaro, N; Dell'Aera, M; Denicolò, S; Di Gennaro, F; Diella, L; Frallonardo, L; Grasso, S; Guido, G; Mosca, A; Papagni, R; Pellegrino, C; Pomarico, F; Ronga, L; Saracino, A; Stufano, M	1
Caseris, M; Cohen, R; Dortet, L; Lorrot, M; Raymond, J; Toubiana, J	1
Davis, KA; Fillius, AG; McClain, DL; Nisly, SA	1
Dash, S; Gupta, K	1
Demoré, B; Duval, RE; Grare, M	1
Briscoe, S; Lipman, J; McWhinney, B; Nunez-Nunez, M; Rhodes, NJ; Roberts, JA; Scheetz, MH; Taccone, F; Ungerer, J; Villois, P; Wong, G	1
Kharat, AS; Khobragade, K; Palwe, S	1
Al-Hasan, MN; Bookstaver, PB; Drennan, C; Gould, AP; Hill, O; Justo, JA; Kohn, J	1
Ammerlaan, HSM; Bonten, MJM; Buiting, AGM; Deelen, JWT; Dorigo-Zetsma, JW; Kluytmans, JAJW; Rottier, WC; Thijsen, SFT; van der Linden, PD; van Werkhoven, CH; Vlaminckx, BJM; Weersink, AJL	1
da Costa, WF; Giambiagi-deMarval, M; Laport, MS	1
Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y	1
Abdul-Aziz, MH; Portunato, F; Roberts, JA	1
Kois, AK; Kuti, JL; Nicolau, DP	1
Bassetti, M; Battaglini, D; Giacobbe, DR; Pelosi, P; Vena, A	1
Ahmed, N; Decano, A; Dubrovskaya, Y; Jen, SP; Marsh, K; Merchan, C; Papadopoulos, J; Siegfried, J	1
Jiménez, JN; Salazar-Ospina, L; Vanegas, JM	1
Andrews, B; Bifulco, N; Carter, NM; Chen, B; Comita-Prevoir, J; de Jonge, B; Durand-Réville, TF; Ehmann, DE; Gao, N; Giacobbe, RA; Guler, S; Huynh, H; Lahiri, S; McLaughlin, R; McLeod, SM; Miller, AA; Moussa, SH; Mueller, JP; Newman, JV; O'Donnell, J; Olivier, NB; Palmer, T; Shapiro, AB; Thresher, J; Tommasi, RA; Velez-Vega, C	1
Auerbach, AD; Dvorak, CC; Levy, ER; Sabnis, AJ; Wattier, RL	1
Kollef, MH; Micek, ST; Vazquez, R; Vazquez-Guillamet, MC	1
Ding, S; Huang, Y; Li, C; Ling, H; Shen, J; Wang, Z; Xu, Y	1
Forstner, C; Pletz, MW; Wagenlehner, F; Weis, S	2
Aznar, J; Barrón-Adúriz, R; Calvo, J; Cantón, R; Castillo, FJ; Cercenado, E; Cisterna, R; González-Romo, F; López-Hontangas, JL; López-Mendoza, D; Loza, E; Molloy, B; Suárez-Barrenechea, AI; Tubau, F	1
Geginat, G; Probst-Kepper, M	1
Naber, KG; Wagenlehner, FME	1
Galani, I; Giamarellou, H; Karaiskos, I; Souli, M	1
Bonomo, RA; Boyce, JD; Bulitta, JB; Chen, MJ; Deveson Lucas, D; Drusano, GL; Jiao, Y; Kim, TH; Louie, A; Moya, B; Sutaria, DS; Tao, X; Tsai, H; Tsuji, BT; Zavascki, AP	1
Bulman, ZP; Lenhard, JR	1
Adang, EMM; Bruggemann, R; Dan Do, TN; Kolwijck, E; Nguyen, CP; Ten Oever, J; Wertheim, HFL	1
Falagas, ME; Kapaskelis, A; Tansarli, GS; Vardakas, KZ	1
Cosgrove, SE; Harris, AD; Hsu, AJ; Milstone, AM; Tamma, PD; Turnbull, AE	1
Beardsley, JR; Johnson, JW; Koliscak, LP; Luther, VP; Miller, DP; Ohl, CA; Williamson, JC	1
Xu, ZQ; Xu, ZY	1
Chlebicki, MP; Kwa, AL; Lee, AL; Lee, W; Liew, LT; Lim, CL; Nah, SC; Wan, CN	1
Aubert, G; Carricajo, A; Fonsale, N; Guezzou, S; Verhoeven, PO	1
DePestel, DD; Eyler, RF; Heung, M; Kinzig, M; Mueller, BA; Nader, AM; Pleva, M; Sörgel, F; Sowinski, KM; Vilay, AM	1
Grozinsky-Glasberg, S; Lador, A; Leibovici, L; Paul, M	1
Sick, AC; Tamma, PD; Tschudin-Sutter, S; Turnbull, AE; Weissman, SJ	1
Arlet, G; Baba Ahmed-Kazi Tani, Z	1
Badal, RE; Biedenbach, DJ; Bouchillon, SK; Hackel, M; Hoban, DJ; Nga, TT; Phuong, DM; Phuong, NT; Phuong, TT	1
Gao, H; Jin, M; Jin, S; Ju, L; Mao, Y; Sun, Y; Yin, J	1
Bassetti, M; Righi, E	1
Butterfield, JM; Lodise, TP; Nicasio, AM; Rahme, C	1
Aoki, K; Ishii, Y; Nichols, WW; Tateda, K; Testa, R; Yoshizumi, A	1
Barloy-Hubler, F; Bonnaure-Mallet, M; Bousarghin, L; Dupin, C; Dupont, A; Ehrmann, E; Jolivet-Gougeon, A; Tamanai-Shacoori, Z	1
Araujo-Melendez, J; Criollo, E; Macias-Hernandez, AE; Ponce-de-Leon, A; Ponce-de-Leon, S; Rodriguez-Osorio, CA; Sanchez-Martinez, CO; Sifuentes-Osornio, J	1
Barreto, JN; Tosh, PK; Vasoo, S	1
Cantón, R; Giani, T; Morosini, MI; Nichols, WW; Nordmann, P; Rossolini, GM; Seifert, H; Stefanik, D; Testa, R	1
D'Agostino, C; Rhodes, NJ; Roberts, JA; Scheetz, MH; Skoglund, E	1
Bonnaure-Mallet, M; Gautier, P; Jolivet-Gougeon, A; Monfort, C; Oliviero, N; Tamanai-Shacoori, Z	1
Livermore, DM; Mushtaq, S; Warner, M; Woodford, N	1
Bush, K	1
Fujita, J; Hagihara, M; Hirai, J; Kinjo, T; Mikamo, H; Sakanashi, D; Suematsu, H; Yamagishi, Y	1
Bork, JT; D'Angelo, RG; Heil, EL; Johnson, JK	1
Ammenouche, N; Castelain, S; Choquet, M; Decroix, V; Guiheneuf, R; Pluquet, E	1
Anitha, V; Maneksha, V; Meenakshi, R; Ramakrishnan, R; Rameshkumar, G; Shivkumar, C; Venugopal Reddy, YC	1
Al-Hasan, MN; Ereshefsky, BJ; Gokun, Y; Martin, CA	1
Bader, MS; Brooks, AA; Loeb, M	1
Andersson, AF; Bergman, P; Özenci, V; Zangenah, S	1
Walsh, TR	2
Goff, DA; Mangino, JE	1
Basso, M; Costa, SF; Gobara, S; Gomez, LB; Levin, AS; Oshiro, I; Paez, JG; Spadão, F	1
Chan, J; Leo, YS; Lye, DC; Teng, CP; Wijaya, L	1
Haldorsen, B; Lundblad, EW; Samuelsen, O; Simonsen, GS; Sundsfjord, A	1
Al-Hasan, MN; Baddour, LM; Eckel-Passow, JE; Lahr, BD; Thomsen, KM; Tleyjeh, IM; Vetter, EA; Wilson, JW	1
Anderson, DJ; Chen, LF; Sexton, DJ; Trinh, JV	1
Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ; Hsueh, PR; Paterson, DL	1
Hsueh, PR; Ko, WC	1
Danner, RL; Henning, SA; Moriyama, B; Neuhauser, MM; Walsh, TJ	1
Acred, P; Ryan, DM; Sowa, MA; Watts, CM	1
Appelbaum, PC; Credito, K; Kosowska-Shick, K	1
Bazaz, R; Chapman, AL; Winstanley, TG	1
Chen, BY; Chu, YZ; Nian, H; Shang, H; Sun, GQ; Tian, SF	1
Bogomolova, NS; Bol'shakov, LV; Kuznetsova, SM; Oreshkina, TD	1
Hasegawa, Y; Hatakeyama, K; Kawamura, I; Kojima, S; Ohkura, T; Ohkusu, K; Takahashi, Y; Yagi, T	1
Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ	1
Chong, Y; Docquier, JD; Jeong, SH; Kim, CK; Lee, K; Seo, YH; Yong, D; Yum, JH	1
Filioussis, G; Karavanis, E; Kritas, SK; Petridou, E	1
Aboltins, CA; Buising, KL; Choong, PF; Daffy, JR; Dowsey, MM; Peel, TN; Stanley, PA	1
Salman, S; Van Sickels, JE; Young, M	1
Ernst, EJ; Johnson, SJ; Moores, KG	1
Jenh, AM; Milstone, AM; Tamma, PD	1
Chouchani, C; El Salabi, A; Marrakchi, R	1
Alaniz, C; Carver, PL; DePestel, DD; Newton, D; Pleva, M; Pogue, JM	1
Putcha, N; Rinke, ML; Suh, YD; Tamma, PD; Van Arendonk, KJ	1
MacGowan, A	1
Abuzenadah, AM; Alam, Q; Azhar, EI; Damanhouri, GA; Jabir, NR; Kamal, MA; Shakil, S; Tabrez, S	1
Campos, JM; Malloy, AM	1
Farbman, L; Leibovici, L; Paul, M; Yahav, D	1
Charles, PG; Grayson, ML; Johnson, PD; Teh, B	1
Rice, LB	1
Chang, CM; Chen, PL; Chiu, YC; Ko, WC; Lee, CC; Lee, HC; Lee, NY; Lin, YT; Wu, CJ; Wu, JJ; Yan, JJ	1
Almuzara, MN; Barberis, CM; Famiglietti, AM; Ramirez, MS; Rodríguez, CH; Vay, CA	1
Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Ni, Y; Tang, HJ; Toh, HS; Wang, JH; Xu, Y; Yu, KW	1
Cosgrove, SE; Maragakis, LL; Tamma, PD	1
Trott, D	1
Chen, PL; Ko, WC; Wu, CJ	1
Eller, C; Pfeifer, Y	1
Hsueh, PR; Lai, CC; Lee, CM; Lee, MC; Wang, YY	1
Arnold, HM; Hampton, NB; Hoban, A; Hoffmann, J; Hollands, JM; Juang, PH; Kollef, MH; McCormick, S; Micek, ST; Reichley, RM; Skrupky, LP; Smith, JR	1
Majiduddin, FK; Materon, IC; Palzkill, TG	1
Bartizal, KF; Hicks, PS; Motyl, M; Pelak, B; Woods, GL	1
Carides, A; Choe, KA; Christou, NV; Dellinger, EP; Fernandez, A; Malafaia, O; Rotstein, OD; Satishchandran, V; Solomkin, JS; Tellado, JM; Teppler, H; Yellin, AE	1
Peña, C; Pujol, M	1
Agarwal, SK; Gupta, MK; Jain, A; Kumar, M; Roy, I	1
Mack, D; Stürenburg, E	1
Fujiwara, H; Ikawa, S; Kataoka, D; Kawakami, T; Tanaka, Y; Tanimoto, A	1
Huang, ST; Ko, WC; Lee, HC; Lee, NY; Liu, KH; Yan, JJ	1
Jacoby, GA; Munoz-Price, LS	1
Bonfiglio, G; Lanzafame, A; Mattina, R; Santini, L	1
Burgess, DS; Frei, CR	2
Nordmann, P; Poirel, L; Toleman, MA; Walsh, TR	1
Dittrich, E; Guttmann, C; Meyer, B; Schmaldienst, S; Thalhammer, F	1
Chan, CY; Dinubile, MJ; Friedland, I; Giezek, H; Motyl, MR; Quinn, JP; Shivaprakash, M; Weinstein, RA	1
Avlamis, A; Katsandri, A; Legakis, NJ; Pantazatou, A; Papaparaskevas, J	1
Darbas, H; Diego, I; Gouby, A; Jean-Pierre, H; Jeannot, JL; Jumas-Bilak, E; Marchandin, H; Teyssier, C	1
Chen, WH; Hsueh, PR; Luh, KT	1
Lolans, K; Quinn, JP; Suárez, CJ; Villegas, MV	1
Grozinsky, S; Leibovici, L; Paul, M; Silbiger, I; Soares-Weiser, K	1
Alba, J; Ishii, Y; Kimura, S; Yamaguchi, K	1
Barra, D; Bozzi, A; Cirioni, O; Di Giulio, A; Ghiselli, R; Giacometti, A; Luzi, C; Mangoni, ML; Mocchegiani, F; Orlando, F; Rinaldi, AC; Saba, V; Scalise, G; Silvestri, C	1
Baek, JY; Heo, ST; Ko, KS; Kwon, KT; Lee, JY; Lee, MY; Lee, NY; Oh, WS; Park, S; Peck, KR; Ryu, SY; Song, JH	1
Bernander, S; Ericson, E; Fraenkel, CJ; Larsson, P; Melhus, A; Rydberg, J; Törnqvist, E; Ullberg, M	1
Harbarth, S; Nobre, V; Pittet, D	1
Fraser, VJ; Fridkin, SK; Kollef, MH; Merz, LR; Warren, DK	1
Bonnaure-Mallet, M; Jolivet-Gougeon, A; Sixou, JL; Tamanai-Shacoori, Z	1
Hong, SG; Kim, SY; Moland, ES; Thomson, KS	1
Chan, J; Chen, HH; Lye, DC; Teng, CP	1
Fung, CP; Huang, SS; Lee, CW; Lee, N; Lee, SC; Shieh, WB; Siu, LK	1
Abramson, MA; Doern, GV; Eagye, KJ; Gallagher, G; Lockhart, SR; Nicolau, DP; Quinn, JP	1
Naas, T; Nordmann, P; Poirel, L	1
Cantón, R; de la Maza, OM; de la Pedrosa, EG; Martín, O; Morosini, MI	1
Shah, PM	1
Bouziges, N; Jourdan, N; Lavigne, JP; Lemaire, X; Richard, JL; Sotto, A	1
Berg, ML; Crank, CW; Hayden, MK; Philbrick, AH	1
Buijs, J; Dofferhoff, AS; Mouton, JW; van der Meer, JW; Wagenvoort, JH	1
Nicolau, DP	1
Kahr, A; Michéa-Hamzehpour, M; Pechère, JC	1
Garau, J	1
Clarke, A; Roscoe, D	1
Gaus, W; Kern, WV; Kurrle, E; Moritz, T; Reichle, A; Rozdzinski, E; Schmeiser, T	1
Hu, BS; Lau, YJ; Lin, YH; Liu, PY; Shi, ZY; Shyr, JM; Tsai, WS; Tseng, CY	1
Drucker, M; Konigsberger, H; Leibovici, L; Paul, M; Pitlik, SD; Poznanski, O; Samra, Z	1
Falagas, ME	1
Akhan, SA; Hayran, M	1
Doern, GV; Erwin, ME; Hollis, RJ; Jones, RN; Pfaller, MA	1
Seifert, H	1
Denton, M; Hawkey, PM; Keer, V	1
Akatsuka, K; Chimura, T; Funayama, T; Hayashi, Y; Hirayama, T; Kaneko, N; Morisaki, N; Murayama, K; Numazaki, M; Oda, T; Sato, F	1
Doern, GV; Jones, RN; Pfaller, MA; Salazar, JC	1
Karasawa, T; Kuriyama, T; Nakagawa, K; Nakamura, S; Saiki, Y; Yamamoto, E	1
Cattier, B; Gousset, N; Harriau, P; Philippon, A; Quentin, R; Rosenau, A	1
Levesque, RC; Therrien, C	1
Medeiros, AA	1
Bradford, PA	1
Dandekar, PK; Nicolau, DP; Nightingale, CH; Quintiliani, R	1
Bartizal, K; Gesser, RM; Motyl, M; Pelak, BA; Woods, GL	1
Arlet, G; Bergogne-Bérézin, E; Danglot, C; Decré, D; Fournier, G; Lucet, JC; Philippon, A	1
Collins, T; Gerding, DN	1

Reviews

58 review(s) available for beta-lactams and Bacterial Infections, Gram-Negative

Article	Year
Resistance to beta-lactams in Gram-negative bacilli: relevance and potential therapeutic alternatives. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2022, Volume: 35 Suppl 2 Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cattle; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Microbial Sensitivity Tests; Quinolones; Tetracyclines	2022
Treatment of Resistant Gram-negative bacilli in children. Infectious diseases now, 2023, Volume: 53, Issue:8S Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Child; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans	2023
Fight Against Antimicrobial Resistance: We Always Need New Antibacterials but for Right Bacteria. Molecules (Basel, Switzerland), 2019, Aug-29, Volume: 24, Issue:17 Topics: Acinetobacter baumannii; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Drug Approval; Drug Resistance, Multiple, Bacterial; Drugs, Investigational; Enterobacteriaceae; Fluoroquinolones; Global Health; Glycopeptides; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Macrolides; Pseudomonas aeruginosa	2019
Preserving the Dwindling β-lactams-Based Empiric Therapy Options for Gram-Negative Infections in Challenging Resistance Scenario: Lessons Learned and Way Forward. Microbial drug resistance (Larchmont, N.Y.), 2020, Volume: 26, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillins	2020
Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2 Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea	2022
Prolonged infusion of beta-lactam antibiotics for Gram-negative infections: rationale and evidence base. Current opinion in infectious diseases, 2020, Volume: 33, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Critical Illness; Cystic Fibrosis; Drug Monitoring; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Infusions, Intravenous; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections; Severity of Illness Index	2020
Unresolved issues in the identification and treatment of carbapenem-resistant Gram-negative organisms. Current opinion in infectious diseases, 2020, Volume: 33, Issue:6 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Genotyping Techniques; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2020
The role of new antimicrobials for Gram-negative infections in daily clinical practice. Current opinion in infectious diseases, 2020, Volume: 33, Issue:6 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactams; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Polymyxins; Sisomicin; Tazobactam; Tetracyclines	2020
[New Antibiotics for Treatment of Highly Resistant Gram-negative Bacteria]. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 2018, Volume: 53, Issue:7-08 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans	2018
Novel β-lactam-β-lactamase inhibitor combinations: expectations for the treatment of carbapenem-resistant Gram-negative pathogens. Expert opinion on drug metabolism & toxicology, 2019, Volume: 15, Issue:2 Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans	2019
Comparable Efficacy and Better Safety of Double β-Lactam Combination Therapy versus β‑Lactam plus Aminoglycoside in Gram-Negative Bacteria in Randomized, Controlled Trials. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:7 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Randomized Controlled Trials as Topic; Tobramycin; Treatment Outcome	2019
Inoculum effect of β-lactam antibiotics. The Journal of antimicrobial chemotherapy, 2019, 10-01, Volume: 74, Issue:10 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; beta-Lactams; Disease Models, Animal; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hydrolysis; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome	2019
Clinical cure rate and cost-effectiveness of carbapenem-sparing beta-lactams vs. meropenem for Gram-negative infections: A systematic review, meta-analysis, and cost-effectiveness analysis. International journal of antimicrobial agents, 2019, Volume: 54, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactams; Cost-Benefit Analysis; Gram-Negative Bacterial Infections; Humans; Meropenem	2019
Ertapenem use and antimicrobial resistance to group 2 carbapenems in Gram-negative infections: a systematic review. Expert review of anti-infective therapy, 2013, Volume: 11, Issue:1 Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Pseudomonas aeruginosa	2013
[Recent progress in development of antibiotics against Gram-negative bacteria]. Yao xue xue bao = Acta pharmaceutica Sinica, 2013, Volume: 48, Issue:7 Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; beta-Lactamase Inhibitors; beta-Lactams; Drug Discovery; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Ferrous Compounds; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Peptides; Peptidomimetics; Tetracyclines	2013
Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis. The Cochrane database of systematic reviews, 2014, Jan-07, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cause of Death; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Randomized Controlled Trials as Topic	2014
[News of antibiotic resistance among Gram-negative bacilli in Algeria]. Pathologie-biologie, 2014, Volume: 62, Issue:3 Topics: Algeria; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Sulfonamides	2014
Eravacycline for the treatment of intra-abdominal infections. Expert opinion on investigational drugs, 2014, Volume: 23, Issue:11 Topics: Administration, Oral; Animals; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Tetracyclines	2014
Dual beta-lactam therapy for serious Gram-negative infections: is it time to revisit? Diagnostic microbiology and infectious disease, 2014, Volume: 80, Issue:4 Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Gram-Negative Bacterial Infections; Humans; Penicillin-Binding Proteins; Pseudomonas aeruginosa	2014
Oral Gram-negative anaerobic bacilli as a reservoir of β-lactam resistance genes facilitating infections with multiresistant bacteria. International journal of antimicrobial agents, 2015, Volume: 45, Issue:2 Topics: beta-Lactams; Disease Reservoirs; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Gram-Negative Anaerobic Bacteria; Gram-Negative Bacterial Infections; Humans; Mouth	2015
Emerging issues in gram-negative bacterial resistance: an update for the practicing clinician. Mayo Clinic proceedings, 2015, Volume: 90, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Global Health; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Incidence; Infection Control	2015
A resurgence of β-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens. International journal of antimicrobial agents, 2015, Volume: 46, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Clinical Trials as Topic; Drug Discovery; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans	2015
Osteomyelitis caused by Veillonella species: Case report and review of the literature. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016, Volume: 22, Issue:6 Topics: Adult; beta-Lactams; Debridement; Drug Therapy, Combination; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Osteomyelitis; Veillonella	2016
Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria. Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:7 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Aerobic Bacteria; Gram-Negative Bacterial Infections; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination	2016
An update on the management of urinary tract infections in the era of antimicrobial resistance. Postgraduate medicine, 2017, Volume: 129, Issue:2 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Comorbidity; Drug Resistance, Bacterial; Fluoroquinolones; Fosfomycin; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Minocycline; Nitrofurantoin; Severity of Illness Index; Urinary Tract Infections	2017
Clinically significant carbapenemases: an update. Current opinion in infectious diseases, 2008, Volume: 21, Issue:4 Topics: Acinetobacter; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Gram-Negative Bacterial Infections; Humans; Pseudomonas aeruginosa	2008
[Broad-spectrum beta-lactamases in Gram-negative bacteria]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2008, Dec-04, Volume: 128, Issue:23 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Monobactams; Penicillins; Plasmids	2008
Continuous-infusion beta-lactam antibiotics during continuous venovenous hemofiltration for the treatment of resistant gram-negative bacteria. The Annals of pharmacotherapy, 2009, Volume: 43, Issue:7 Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Clinical Trials as Topic; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hemofiltration; Humans; Infusions, Intravenous; Microbial Sensitivity Tests	2009
Prolonged β-lactam infusion for Gram-negative Infections. The Pediatric infectious disease journal, 2011, Volume: 30, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactams; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Time Factors	2011
Evolution of β-lactams resistance in Gram-negative bacteria in Tunisia. Critical reviews in microbiology, 2011, Volume: 37, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Prevalence; Tunisia	2011
Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials. BMC infectious diseases, 2011, Jun-22, Volume: 11 Topics: Anti-Bacterial Agents; beta-Lactams; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Randomized Controlled Trials as Topic; Treatment Outcome	2011
Revisiting Beta-lactams - PK/PD improves dosing of old antibiotics. Current opinion in pharmacology, 2011, Volume: 11, Issue:5 Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Drug Administration Schedule; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Injections, Intravenous; Microbial Sensitivity Tests	2011
New Delhi metallo-β-lactamase (NDM-1): an update. Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:5 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Biotransformation; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Global Health; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Molecular Targeted Therapy; Sulbactam	2011
Extended-spectrum beta-lactamases: a brief clinical update. The Pediatric infectious disease journal, 2011, Volume: 30, Issue:12 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests	2011
Colistin: new lessons on an old antibiotic. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Clinical Trials as Topic; Colistin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans	2012
Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones. Mayo Clinic proceedings, 2012, Volume: 87, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Clinical Trials as Topic; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Glycopeptides; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests	2012
Combination therapy for treatment of infections with gram-negative bacteria. Clinical microbiology reviews, 2012, Volume: 25, Issue:3 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Clinical Trials as Topic; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Neutropenia; Treatment Outcome	2012
β-lactam resistance in gram-negative pathogens isolated from animals. Current pharmaceutical design, 2013, Volume: 19, Issue:2 Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cephalosporins; Dogs; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Livestock; Pets; Zoonoses	2013
Complexity of β-lactamases among clinical Aeromonas isolates and its clinical implications. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2012, Volume: 45, Issue:6 Topics: Aeromonas; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Species Specificity	2012
Molecular analysis of beta-lactamase structure and function. International journal of medical microbiology : IJMM, 2002, Volume: 292, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Structure-Activity Relationship	2002
Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. The Journal of infection, 2003, Volume: 47, Issue:4 Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infection Control; Microbial Sensitivity Tests; Risk Factors	2003
The new beta-lactamases. The New England journal of medicine, 2005, Jan-27, Volume: 352, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Disease Outbreaks; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Molecular Conformation; Risk Factors	2005
Metallo-beta-lactamases: the quiet before the storm? Clinical microbiology reviews, 2005, Volume: 18, Issue:2 Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans	2005
The emergence and implications of metallo-beta-lactamases in Gram-negative bacteria. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11 Suppl 6 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Genes, Bacterial; Global Health; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Hydrolysis; Integrons; Risk Factors	2005
Mechanisms of resistance to beta-lactams in some common Gram-negative bacteria causing nosocomial infections. Expert review of anti-infective therapy, 2005, Volume: 3, Issue:6 Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans	2005
Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis. The Cochrane database of systematic reviews, 2006, Jan-25, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cause of Death; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Randomized Controlled Trials as Topic	2006
Does antibiotic selection impact patient outcome? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Jan-01, Volume: 44, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Pneumonia, Pneumococcal; Prognosis; Sepsis; Survival Rate	2007
Antimicrobial treatment of Capnocytophaga infections. International journal of antimicrobial agents, 2007, Volume: 29, Issue:4 Topics: Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Capnocytophaga; Cilastatin; Clindamycin; Endocarditis, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Immunocompromised Host; Microbial Sensitivity Tests	2007
Minor extended-spectrum beta-lactamases. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008, Volume: 14 Suppl 1 Topics: Amino Acid Substitution; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Chromosomes, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Plasmids	2008
IRT and CMT beta-lactamases and inhibitor resistance. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008, Volume: 14 Suppl 1 Topics: Amino Acid Substitution; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Urinary Tract Infections	2008
Parenteral carbapenems. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008, Volume: 14 Suppl 1 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Humans; Imipenem; Infusions, Parenteral; Meropenem; Thienamycins	2008
Pharmacodynamic optimization of beta-lactams in the patient care setting. Critical care (London, England), 2008, Volume: 12 Suppl 4 Topics: beta-Lactams; Drug Resistance, Bacterial; Drug Resistance, Multiple; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests	2008
Beta-lactamases: current situation and clinical importance. Intensive care medicine, 1994, Volume: 20 Suppl 3 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Enzyme Induction; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Plasmids	1994
Molecular basis of antibiotic resistance and beta-lactamase inhibition by mechanism-based inactivators: perspectives and future directions. FEMS microbiology reviews, 2000, Volume: 24, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans	2000
Cooperative evolution of mechanisms of beta-lactam resistance. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2000, Volume: 6 Suppl 3 Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Evolution, Molecular; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Protein Conformation	2000
Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clinical microbiology reviews, 2001, Volume: 14, Issue:4 Topics: Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Phylogeny; Substrate Specificity	2001
Extended-spectrum beta-lactamases (ESBL). Connecticut medicine, 2002, Volume: 66, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Gram-Negative Bacterial Infections; Humans	2002
Aminoglycosides versus beta-lactams in gram-negative pneumonia. Seminars in respiratory infections, 1991, Volume: 6, Issue:3 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Bronchi; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Pneumonia	1991

Trials

7 trial(s) available for beta-lactams and Bacterial Infections, Gram-Negative

Article	Year
Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2 Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea	2022
Pharmacokinetics of ertapenem in critically ill patients receiving continuous venovenous hemodialysis or hemodiafiltration. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3 Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Critical Illness; Ertapenem; Female; Gram-Negative Bacterial Infections; Hemofiltration; Humans; Male; Middle Aged; Renal Dialysis	2014
Prolonged infusion antibiotics for suspected gram-negative infections in the ICU: a before-after study. The Annals of pharmacotherapy, 2013, Volume: 47, Issue:2 Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Cohort Studies; Cross Infection; Drug Administration Schedule; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, Teaching; Hospitals, Urban; Humans; Infusions, Intravenous; Intensive Care Units; Length of Stay; Male; Meropenem; Middle Aged; Missouri; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins	2013
Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial. Annals of surgery, 2003, Volume: 237, Issue:2 Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Digestive System Surgical Procedures; Double-Blind Method; Drug Therapy, Combination; Ertapenem; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospitalization; Humans; Lactams; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Research Design; Treatment Outcome	2003
Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2005, Volume: 24, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Carrier State; Ceftriaxone; Digestive System Surgical Procedures; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intestines; Lactams; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination	2005
Once-daily versus thrice-daily dosing of netilmicin in combination with beta-lactam antibiotics as empirical therapy for febrile neutropenic patients. The Journal of antimicrobial chemotherapy, 1993, Volume: 31, Issue:4 Topics: Anemia, Aplastic; Anti-Bacterial Agents; beta-Lactams; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Netilmicin; Neutropenia; Prospective Studies	1993
[Clinical studies of faropenem in the field of obstetrics and gynecology]. The Japanese journal of antibiotics, 1999, Volume: 52, Issue:7 Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cystitis; Female; Genital Diseases, Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Lactams; Mastitis; Middle Aged; Pelvic Inflammatory Disease; Uterine Cervicitis; Uterine Diseases	1999

Other Studies

102 other study(ies) available for beta-lactams and Bacterial Infections, Gram-Negative

Article	Year
Resistance to empirical β-lactams recommended in febrile neutropenia guidelines in Gram-negative bacilli bloodstream infections in Spain: a multicentre study. The Journal of antimicrobial chemotherapy, 2022, 06-29, Volume: 77, Issue:7 Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cohort Studies; Febrile Neutropenia; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Pseudomonas aeruginosa; Retrospective Studies; Sepsis; Spain	2022
Interactions of hydrolyzed β-lactams with the L1 metallo-β-lactamase: Crystallography supports stereoselective binding of cephem/carbapenem products. The Journal of biological chemistry, 2023, Volume: 299, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Crystallography; Gram-Negative Bacterial Infections; Humans; Kinetics; Stenotrophomonas maltophilia	2023
Addition of aminoglycosides reduces recurrence of infections with multidrug-resistant Gram-negative bacilli in patients with sepsis and septic shock. International journal of antimicrobial agents, 2023, Volume: 62, Issue:4 Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Retrospective Studies; Sepsis; Shock, Septic	2023
Loading dose plus continuous/extended infusion versus intermittent bolus of β-lactams for the treatment of Gram-negative bacteria bloodstream infections: a propensity score-adjusted retrospective cohort study. The Journal of antimicrobial chemotherapy, 2023, 09-05, Volume: 78, Issue:9 Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Propensity Score; Retrospective Studies; Sepsis	2023
Oral antibiotics for the treatment of Gram-negative bloodstream infections: A retrospective comparison of three antibiotic classes. Journal of global antimicrobial resistance, 2020, Volume: 20 Topics: Administration, Intravenous; Administration, Oral; Aged; Anti-Bacterial Agents; beta-Lactams; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Inpatients; Male; Middle Aged; Retrospective Studies; Sepsis; Survival Analysis; Treatment Failure; Trimethoprim, Sulfamethoxazole Drug Combination	2020
Efficacy of newer β lactams/ β lactamase inhibitors for treatment of multidrug resistant gram negative infections in burn patients. Burns : journal of the International Society for Burn Injuries, 2019, Volume: 45, Issue:7 Topics: Acinetobacter baumannii; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactams; Burns; Carbapenem-Resistant Enterobacteriaceae; Cephalosporins; Drug Combinations; Drug Development; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Pseudomonas aeruginosa	2019
β-Lactam pharmacodynamics in Gram-negative bloodstream infections in the critically ill. The Journal of antimicrobial chemotherapy, 2020, 02-01, Volume: 75, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactams; Critical Illness; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sepsis	2020
Empirical fluoroquinolones versus broad-spectrum beta-lactams for Gram-negative bloodstream infections in the absence of antimicrobial resistance risk factors. Journal of global antimicrobial resistance, 2020, Volume: 22 Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Resistance, Bacterial; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Male; Retrospective Studies; Risk Factors; Sepsis	2020
Short-course aminoglycosides as adjunctive empirical therapy in patients with Gram-negative bloodstream infection, a cohort study. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021, Volume: 27, Issue:2 Topics: Aged; Aged, 80 and over; Aminoglycosides; beta-Lactams; Combined Modality Therapy; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Netherlands; Prospective Studies; Sepsis; Survival Analysis; Treatment Outcome	2021
Shewanella harboring antimicrobial and copper resistance genes in sea urchins (Paracentrotus lividus) from the Crozon peninsula (Brittany, France). Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2020, Volume: 85 Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Copper; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Food Microbiology; France; Gram-Negative Bacterial Infections; Humans; Macrolides; Paracentrotus; Public Health; Quinolones; Shewanella; Tetracycline	2020
Intravenous push versus intravenous piggyback beta-lactams for the empiric management of gram-negative bacteremia. Journal of clinical pharmacy and therapeutics, 2021, Volume: 46, Issue:2 Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies	2021
High intermittent colonization by diverse clones of β-lactam-resistant Gram-negative bacilli suggests an excessive antibiotic use and different sources of transmission in haemodialysis patients. The Journal of hospital infection, 2021, Volume: 107 Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Clone Cells; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Longitudinal Studies; Multilocus Sequence Typing; Renal Dialysis	2021
ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii. Nature microbiology, 2017, Jun-30, Volume: 2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Dogs; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Mice; Models, Molecular; Penicillin-Binding Proteins; Rats; Sulbactam	2017
Reducing Second Gram-Negative Antibiotic Therapy on Pediatric Oncology and Hematopoietic Stem Cell Transplantation Services. Infection control and hospital epidemiology, 2017, Volume: 38, Issue:9 Topics: Adolescent; Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactams; Child; Child, Preschool; Ciprofloxacin; Drug Combinations; Drug Utilization; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Guidelines as Topic; Hematopoietic Stem Cell Transplantation; Hospitals, Pediatric; Humans; Length of Stay; Medical Oncology; Neutropenia; Pediatrics; Poisson Distribution; San Francisco; Tobramycin; Treatment Outcome	2017
Predicting Resistance to Piperacillin-Tazobactam, Cefepime and Meropenem in Septic Patients With Bloodstream Infection Due to Gram-Negative Bacteria. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, Oct-30, Volume: 65, Issue:10 Topics: Adult; Aged; Algorithms; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactams; Decision Trees; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Prevalence; Retrospective Studies; Risk Factors	2017
Detection of AmpC β-lactamase-producing Gram-negative bacteria by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. The Journal of hospital infection, 2018, Volume: 99, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Culture Media; Genotype; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Phenotype; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors	2018
[Urosepsis]. Der Urologe. Ausg. A, 2018, Volume: 57, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Sepsis; Urinary Tract Infections	2018
[Urosepsis]. Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2018, Volume: 113, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Sepsis; Urinary Tract Infections	2018
Antimicrobial susceptibility trends and evolution of isolates with extended spectrum β-lactamases among Gram-negative organisms recovered during the SMART study in Spain (2011-2015). Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2018, Volume: 31, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Drug Combinations; Ertapenem; Escherichia coli; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Spain	2018
Novel Antibiotics in the Treatment of Urinary Tract Infections. European urology focus, 2019, Volume: 5, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Clinical Trials as Topic; Cystitis; Drug Resistance, Bacterial; Drug Therapy, Combination; Drug Utilization; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Iatrogenic Disease; Tetracyclines; Urinary Tract Infections	2019
Less is more: combination antibiotic therapy for the treatment of gram-negative bacteremia in pediatric patients. JAMA pediatrics, 2013, Volume: 167, Issue:10 Topics: Adolescent; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Child; Child, Preschool; Comparative Effectiveness Research; Creatine; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Infant; Kidney Diseases; Logistic Models; Male; Propensity Score; Retrospective Studies; Treatment Outcome	2013
Optimizing empiric antibiotic therapy in patients with severe β-lactam allergy. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Hypersensitivity; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Empirical Research; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Middle Aged; Pneumonia, Bacterial; Retrospective Studies; Risk; Tetracycline; Urinary Tract Infections	2013
Evaluation of Ertapenem use with impact assessment on extended-spectrum beta-lactamases (ESBL) production and gram-negative resistance in Singapore General Hospital (SGH). BMC infectious diseases, 2013, Nov-06, Volume: 13 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Ertapenem; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, General; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Singapore; Thienamycins; Young Adult	2013
Detection of carbapenemase-producing bacteria by using an ultra-performance liquid chromatography-tandem mass spectrometry method. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Chromatography, High Pressure Liquid; Enzyme Assays; Gene Expression; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Plasmids; Pseudomonas aeruginosa; Tandem Mass Spectrometry	2014
Empiric combination therapy for gram-negative bacteremia. Pediatrics, 2014, Volume: 133, Issue:5 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Baltimore; beta-Lactams; Child; Child, Preschool; Cohort Studies; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Empiricism; Female; Gram-Negative Bacterial Infections; Humans; Infant; Kaplan-Meier Estimate; Male; Neutropenia; Odds Ratio; Opportunistic Infections; Propensity Score; Retrospective Studies; Survival Analysis	2014
Antimicrobial susceptibility and extended-spectrum beta-lactamase rates in aerobic gram-negative bacteria causing intra-abdominal infections in Vietnam: report from the Study for Monitoring Antimicrobial Resistance Trends (SMART 2009-2011). Diagnostic microbiology and infectious disease, 2014, Volume: 79, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Vietnam	2014
Distinct roles of major peptidoglycan recycling enzymes in β-Lactamase production in Shewanella oneidensis. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11 Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; beta-N-Acetylhexosaminidases; DNA-Binding Proteins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Gene Knockout Techniques; Gram-Negative Bacterial Infections; Membrane Transport Proteins; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Peptidoglycan; Promoter Regions, Genetic; Pseudomonas aeruginosa; Shewanella	2014
In vitro susceptibility of characterized β-lactamase-producing Gram-negative bacteria isolated in Japan to ceftazidime-, ceftaroline-, and aztreonam-avibactam combinations. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:2 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Japan; Microbial Sensitivity Tests	2015
Impact of ertapenem on antimicrobial resistance in a sentinel group of Gram-negative bacilli: a 6 year antimicrobial resistance surveillance study. The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Retrospective Studies; Sentinel Surveillance; Tertiary Care Centers	2015
In vitro activity of ceftazidime, ceftaroline and aztreonam alone and in combination with avibactam against European Gram-negative and Gram-positive clinical isolates. International journal of antimicrobial agents, 2015, Volume: 45, Issue:6 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Europe; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests	2015
Microbiologic clearance following transition from standard infusion piperacillin-tazobactam to extended-infusion for persistent Gram-negative bacteremia and possible endocarditis: A case report and review of the literature. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:10 Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Endocarditis; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination	2015
cfxA expression in oral clinical Capnocytophaga isolates. Anaerobe, 2015, Volume: 35, Issue:Pt B Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Capnocytophaga; Gene Expression Profiling; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Mouth Mucosa; Mutagenesis, Insertional; Real-Time Polymerase Chain Reaction; Recombination, Genetic	2015
Activity of OP0595/β-lactam combinations against Gram-negative bacteria with extended-spectrum, AmpC and carbapenem-hydrolysing β-lactamases. The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:11 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; beta-Lactams; Drug Interactions; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Lactams; Microbial Sensitivity Tests; United Kingdom	2015
Place of diagnostic tools in the identification of Anaerobiospirillum succiniciproducens bacteraemia. Anaerobe, 2016, Volume: 39 Topics: Anaerobiospirillum; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Clindamycin; Delayed Diagnosis; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pelvis; RNA, Ribosomal, 16S; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization	2016
Prevalence and antibacterial resistance patterns of extended-spectrum beta-lactamase producing Gram-negative bacteria isolated from ocular infections. Indian journal of ophthalmology, 2016, Volume: 64, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Child; Child, Preschool; DNA, Bacterial; Eye Infections, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Incidence; India; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Prevalence; Prospective Studies; Young Adult	2016
Comparison of ß-lactam plus aminoglycoside versus ß-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli. Journal of chemotherapy (Florence, Italy), 2017, Volume: 29, Issue:1 Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Critical Illness; Cross Infection; Drug Therapy, Combination; Female; Fluoroquinolones; Gentamicins; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Proportional Hazards Models; Retrospective Studies; Tobramycin; Treatment Outcome	2017
Genomic analysis reveals the presence of a class D beta-lactamase with broad substrate specificity in animal bite associated Capnocytophaga species. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017, Volume: 36, Issue:4 Topics: Animals; beta-Lactamases; beta-Lactams; Bites and Stings; Capnocytophaga; Cats; Computational Biology; Disk Diffusion Antimicrobial Tests; Dogs; Genome, Bacterial; Gram-Negative Bacterial Infections; Humans; Substrate Specificity	2017
Ertapenem: no effect on aerobic gram-negative susceptibilities to imipenem. The Journal of infection, 2008, Volume: 57, Issue:2 Topics: beta-Lactamases; beta-Lactams; Drug Interactions; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Aerobic Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Imipenem	2008
Trends in Stenotrophomonas maltophilia bloodstream infection in relation to usage density of cephalosporins and carbapenems during 7 years. Infection control and hospital epidemiology, 2008, Volume: 29, Issue:10 Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Brazil; Carbapenems; Cephalosporins; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Incidence; Stenotrophomonas maltophilia	2008
Ertapenem for treatment of extended-spectrum beta-lactamase-producing and multidrug-resistant gram-negative bacteraemia. Annals of the Academy of Medicine, Singapore, 2008, Volume: 37, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Urinary Tract Infections	2008
Beta-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:4 Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cohort Studies; Drug Therapy, Combination; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies	2009
Risk factors for gram-negative bacterial surgical site infection: do allergies to antibiotics increase risk? Infection control and hospital epidemiology, 2009, Volume: 30, Issue:5 Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Case-Control Studies; Drug Hypersensitivity; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, Community; Humans; Male; Middle Aged; North Carolina; Risk Factors; Surgical Procedures, Operative; Surgical Wound Infection	2009
Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; China; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Imipenem; India; Klebsiella; Quinolones; Thailand	2009
Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006. The Journal of infection, 2009, Volume: 59, Issue:2 Topics: Abdominal Abscess; Animals; Anti-Bacterial Agents; Asia; Australasia; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Prospective Studies; Quinolones	2009
The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin. The Journal of antimicrobial chemotherapy, 1981, Volume: 8 Suppl B Topics: Agar; Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ceftazidime; Cephalosporins; Colony Count, Microbial; Female; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests	1981
Mutant prevention concentrations of four carbapenems against gram-negative rods. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Doripenem; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Genes, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Mutation; Phenotype; Pseudomonas aeruginosa; Thienamycins	2010
Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum-beta-lactamase-producing Gram-negative organisms. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:7 Topics: Adult; Aged; Ambulatory Care; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ertapenem; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Health Care Costs; Humans; Infusions, Intravenous; Male; Middle Aged; Retrospective Studies; Treatment Outcome; United Kingdom; Urinary Tract Infections	2010
Pharmacokinetic-pharmacodynamic profiling of four antimicrobials against gram-negative bacteria collected from Shenyang, China. BMC infectious diseases, 2010, Jun-15, Volume: 10 Topics: Anti-Bacterial Agents; beta-Lactams; China; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans	2010
[Dynamics of acquires resistance in the main gramnegative pathogens of surgical infections to beta-lactams in 2004-2008]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2010, Volume: 55, Issue:1-2 Topics: beta-Lactam Resistance; beta-Lactams; Cross Infection; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Postoperative Complications; Retrospective Studies; Russia	2010
Recurrent vascular catheter-related bacteremia caused by Delftia acidovorans with different antimicrobial susceptibility profiles. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2011, Volume: 17, Issue:1 Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Catheter-Related Infections; Catheters, Indwelling; Child; Delftia acidovorans; DNA, Bacterial; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Japan; Microbial Sensitivity Tests; Neuroblastoma; Opportunistic Infections; Peripheral Blood Stem Cell Transplantation; Polymerase Chain Reaction; RNA, Ribosomal, 16S	2011
Epidemiologic trends, occurrence of extended-spectrum beta-lactamase production, and performance of ertapenem and comparators in patients with intra-abdominal infections: analysis of global trend data from 2002-2007 from the SMART study. Surgical infections, 2010, Volume: 11, Issue:4 Topics: Africa; Animals; Anti-Bacterial Agents; Asia; Australasia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Ertapenem; Europe; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Latin America; Middle East; North America; Peritonitis	2010
Improved performance of the modified Hodge test with MacConkey agar for screening carbapenemase-producing Gram-negative bacilli. Journal of microbiological methods, 2010, Volume: 83, Issue:2 Topics: Agar; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Culture Media; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Mass Screening; Microbial Sensitivity Tests	2010
Stenotrophomonas maltophilia as a causal agent of pyogranulomatous hepatitis in a buffalo (Bubalus bubalis). Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc, 2010, Volume: 22, Issue:5 Topics: Adipose Tissue; Animals; Anti-Bacterial Agents; beta-Lactams; Bilirubin; Buffaloes; Drug Resistance, Microbial; Euthanasia; Female; Gram-Negative Bacterial Infections; Greece; Hepatitis, Animal; Hepatomegaly; Polymerase Chain Reaction; Stenotrophomonas maltophilia; Tetracycline	2010
Gram-negative prosthetic joint infection treated with debridement, prosthesis retention and antibiotic regimens including a fluoroquinolone. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2011, Volume: 17, Issue:6 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Debridement; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Joint Prosthesis; Male; Prosthesis-Related Infections; Survival Analysis; Treatment Outcome	2011
Osteomyelitis after bilateral sagittal split osteotomy: case report and a review of the management. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2011, Volume: 111, Issue:4 Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Bone Plates; Bone Screws; Clindamycin; Drainage; Enterobacteriaceae Infections; Ertapenem; Female; Gram-Negative Bacterial Infections; Humans; Jaw Fixation Techniques; Mandible; Ofloxacin; Open Bite; Orthognathic Surgical Procedures; Osteomyelitis; Osteotomy; Osteotomy, Le Fort; Retrognathia; Streptococcal Infections	2011
Is double coverage of gram-negative organisms necessary? American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2011, Jan-15, Volume: 68, Issue:2 Topics: Aminoglycosides; Anti-Infective Agents; beta-Lactams; Drug Resistance, Microbial; Drug Therapy, Combination; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Neutropenia	2011
Role of unit-specific combination antibiograms for improving the selection of appropriate empiric therapy for gram-negative pneumonia. Infection control and hospital epidemiology, 2011, Volume: 32, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa	2011
Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Australia; beta-Lactams; Chlamydophila; Community-Acquired Infections; Doxycycline; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Legionella; Macrolides; Male; Middle Aged; Mycoplasma; Mycoplasma Infections; Pneumonia, Bacterial; Prospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult	2012
Distribution and phenotypic and genotypic detection of a metallo-β-lactamase, CphA, among bacteraemic Aeromonas isolates. Journal of medical microbiology, 2012, Volume: 61, Issue:Pt 5 Topics: Aeromonas; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; beta-Lactams; DNA, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction	2012
First report of an extensively drug-resistant VIM-2 metallo-β-lactamase-producing Brevundimonas diminuta clinical isolate. Journal of clinical microbiology, 2012, Volume: 50, Issue:8 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Caulobacteraceae; DNA, Bacterial; DNA, Ribosomal; Female; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Middle Aged; RNA, Ribosomal, 16S; Sequence Analysis, DNA	2012
Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). International journal of antimicrobial agents, 2012, Volume: 40 Suppl Topics: Amikacin; Anti-Bacterial Agents; Asia; Australasia; beta-Lactamases; beta-Lactams; Carbapenems; Ceftazidime; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence; Prospective Studies; Urinary Tract Infections	2012
[Current data and trends about the resistance of Gram-negative pathogens to beta-lactams]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2012, Volume: 55, Issue:11-12 Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cephalosporins; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Europe; Germany; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Population Surveillance; Serotyping	2012
Impact of susceptibility profiles of Gram-negative bacteria before and after the introduction of ertapenem at a medical center in northern Taiwan from 2004 to 2010. Diagnostic microbiology and infectious disease, 2013, Volume: 75, Issue:1 Topics: Academic Medical Centers; Anti-Bacterial Agents; beta-Lactams; Drug Utilization; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Retrospective Studies; Taiwan	2013
Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2002, Volume: 8, Issue:11 Topics: Anti-Bacterial Agents; beta-Lactams; Bronchitis, Chronic; Community-Acquired Infections; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lactams; Microbial Sensitivity Tests; Pneumonia, Bacterial	2002
[The clinical significance of broad-spectrum beta-lactamases]. Enfermedades infecciosas y microbiologia clinica, 2003, Volume: 21, Issue:2 Topics: Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Europe; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Incidence	2003
Prevalence of extended-spectrum beta-lactamase-producing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital. Journal of medical microbiology, 2003, Volume: 52, Issue:Pt 5 Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Enterobacter; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Incidence; India; Infant, Newborn; Klebsiella; Microbial Sensitivity Tests; Prevalence	2003
The indirect pathogenicity of Stenotrophomonas maltophilia. International journal of antimicrobial agents, 2003, Volume: 22, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Coculture Techniques; Colony Count, Microbial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Serratia marcescens; Stenotrophomonas maltophilia; Virulence	2003
Clinical experiences of bacteremia caused by metallo-beta-lactamase-producing gram-negative organisms. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2004, Volume: 37, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Carbapenems; Child; Child, Preschool; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged	2004
In vitro activity of levofloxacin against recent Gram-negative nosocomial pathogens. Chemotherapy, 2005, Volume: 51, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin	2005
Continuous infusion beta-lactams for intensive care unit pulmonary infections. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:5 Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Computer Simulation; Drug Combinations; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Intensive Care Units; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; United States	2005
Intermittent administration of betalactam-antibiotics for treatment of severe infection in hemodialysis patients. European journal of medical research, 2005, Apr-20, Volume: 10, Issue:4 Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; C-Reactive Protein; Cefepime; Ceftazidime; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Piperacillin; Renal Dialysis; Treatment Outcome	2005
Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:10 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; beta-Lactams; Carbapenems; Drug Resistance, Microbial; Ertapenem; Gram-Negative Anaerobic Bacteria; Gram-Negative Bacterial Infections; Greece; Humans; Inhibitory Concentration 50; Metronidazole; Microbial Sensitivity Tests	2005
Molecular and phenotypic features for identification of the opportunistic pathogens Ochrobactrum spp. Journal of medical microbiology, 2005, Volume: 54, Issue:Pt 10 Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactams; Colistin; Culture Media; DNA, Bacterial; DNA, Ribosomal; Fermentation; Gentian Violet; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Netilmicin; Ochrobactrum; Opportunistic Infections; Oxidoreductases; Phenazines; Ribotyping; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Temperature; Tobramycin; Urease	2005
Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics. The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections	2005
Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan. International journal of antimicrobial agents, 2005, Volume: 26, Issue:6 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Incidence; Length of Stay; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Taiwan	2005
Evaluation of antimicrobial activity of beta-lactam antibiotics by Etest against clinical isolates from 100 medical centers in Japan (2004). Diagnostic microbiology and infectious disease, 2006, Volume: 55, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Japan; Microbial Sensitivity Tests; Reagent Strips	2006
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:7 Topics: Animals; Anti-Infective Agents; Antimicrobial Cationic Peptides; beta-Lactams; Disease Models, Animal; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Lipopolysaccharides; Male; Microbial Sensitivity Tests; Peritonitis; Piperacillin; Proteins; Rats; Rats, Wistar; Shock, Septic	2006
In vitro activities of ertapenem against drug-resistant Streptococcus pneumoniae and other respiratory pathogens from 12 Asian countries. Diagnostic microbiology and infectious disease, 2006, Volume: 56, Issue:4 Topics: Anti-Bacterial Agents; Asia; Bacterial Infections; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pneumococcal Infections; Respiratory Tract Infections; Sentinel Surveillance; Streptococcus pneumoniae	2006
In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals. Scandinavian journal of infectious diseases, 2006, Volume: 38, Issue:10 Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Enterobacteriaceae; Ertapenem; Gram-Negative Bacterial Infections; Humans; Imipenem; Klebsiella; Meropenem; Microbial Sensitivity Tests; Proteus; Sweden; Thienamycins	2006
The impact of an antibiotic cycling program on empirical therapy for gram-negative infections. Chest, 2006, Volume: 130, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Resistance, Multiple; Empiricism; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospitals, Teaching; Humans; Intensive Care Units; Male; Middle Aged; Missouri; Penicillins; Pneumonia, Bacterial; Prospective Studies; Survival Rate; Urinary Tract Infections; Ventilators, Mechanical	2006
Convenient test using a combination of chelating agents for detection of metallo-beta-lactamases in the clinical laboratory. Journal of clinical microbiology, 2007, Volume: 45, Issue:9 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Chelating Agents; Enzyme Induction; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity	2007
Ertapenem for the treatment of extended-spectrum beta-lactamase-producing Gram-negative bacterial infections. International journal of antimicrobial agents, 2007, Volume: 30, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Ertapenem; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Treatment Outcome	2007
Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan. BMC infectious diseases, 2007, Jul-17, Volume: 7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacteria, Aerobic; beta-Lactams; Child; Child, Preschool; Community-Acquired Infections; Ertapenem; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Taiwan	2007
A pharmacodynamic analysis of resistance trends in pathogens from patients with infection in intensive care units in the United States between 1993 and 2004. Annals of clinical microbiology and antimicrobials, 2007, Oct-01, Volume: 6 Topics: Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Microbial Sensitivity Tests; Monte Carlo Method; United States	2007
[In vitro activity of ertapenem against strains isolated from diabetic foot infections]. Medecine et maladies infectieuses, 2008, Volume: 38, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Diabetic Foot; Drug Evaluation, Preclinical; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Inpatients; Microbial Sensitivity Tests; Species Specificity; Staphylococcal Infections	2008
Efficacy of ertapenem for consolidation therapy of extended-spectrum beta-lactamase-producing gram-negative infections: a case series report. The Annals of pharmacotherapy, 2008, Volume: 42, Issue:2 Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Ertapenem; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies	2008
Concentration-dependency of beta-lactam-induced filament formation in Gram-negative bacteria. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008, Volume: 14, Issue:4 Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cefotaxime; Ceftazidime; Colony Count, Microbial; Dose-Response Relationship, Drug; Endotoxins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas	2008
In vitro stepwise selection of resistance to quinolones, beta-lactams and amikacin in nosocomial gram-negative bacilli. Infection, 1994, Volume: 22 Suppl 2 Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Evaluation Studies as Topic; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Infection Control; Risk Factors	1994
Resistance of Capnocytophaga species to beta-lactam antibiotics. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 17, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Capnocytophaga; Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Humans	1993
Comparison of susceptibility to extended-spectrum beta-lactam antibiotics and ciprofloxacin among gram-negative bacilli isolated from intensive care units. Diagnostic microbiology and infectious disease, 1995, Volume: 22, Issue:3 Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Microbial Sensitivity Tests	1995
Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Child; Child, Preschool; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Logistic Models; Male; Middle Aged; Prospective Studies; Risk Factors; Treatment Outcome	1997
Monotherapy versus beta-lactam-aminoglycoside combination therapy for gram-negative bacteremia. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:11 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans	1997
Treatment with beta-lactams and superinfection with Stenotrophomonas maltophilia: a historical cohort study could show us more. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 26, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Gram-Negative Bacterial Infections; Humans; Superinfection	1998
Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group. Diagnostic microbiology and infectious disease, 1998, Volume: 30, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Microbial; Gram-Negative Aerobic Rods and Cocci; Gram-Negative Anaerobic Bacteria; Gram-Negative Bacterial Infections; Gram-Negative Facultatively Anaerobic Rods; Humans	1998
Comparative in-vitro activities of trovafloxacin, ciproflaxacin, ofloxacin, and broad-spectrum beta-lactams against aerobe blood culture isolates. Zentralblatt fur Bakteriologie : international journal of medical microbiology, 1998, Volume: 288, Issue:4 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Bacteria, Aerobic; Bacterial Infections; beta-Lactams; Blood; Culture Media; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Naphthyridines	1998
Correlation between genotype and beta-lactamases of clinical and environmental strains of Stenotrophomonas maltophilia. The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cystic Fibrosis; Electrophoresis, Gel, Pulsed-Field; Gram-Negative Bacterial Infections; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Sputum; Xanthomonas	1999
Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia: comparison of data from 1997 and 1998 using the Etest method. The Colombian Antimicrobial Resistance Study Group. Diagnostic microbiology and infectious disease, 1999, Volume: 35, Issue:3 Topics: beta-Lactam Resistance; beta-Lactams; Colombia; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Laboratories, Hospital; Microbial Sensitivity Tests; Oxacillin; Penicillins; Staphylococcal Infections; Staphylococcus aureus	1999
Past administration of beta-lactam antibiotics and increase in the emergence of beta-lactamase-producing bacteria in patients with orofacial odontogenic infections. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2000, Volume: 89, Issue:2 Topics: Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Chi-Square Distribution; Contraindications; Dermatitis, Perioral; Focal Infection, Dental; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Middle Aged; Patient Care Planning	2000
Capnocytophaga ochracea: characterization of a plasmid-encoded extended-spectrum TEM-17 beta-lactamase in the phylum Flavobacter-bacteroides. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:3 Topics: Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Capnocytophaga; Gram-Negative Bacterial Infections; Humans; Isoelectric Point; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA	2000
Ertapenem (Invanz)--a new parenteral carbapenem. The Medical letter on drugs and therapeutics, 2002, Mar-18, Volume: 44, Issue:1126 Topics: Anti-Bacterial Agents; beta-Lactams; Clinical Trials as Topic; Community-Acquired Infections; Dose-Response Relationship, Drug; Ertapenem; Gram-Negative Bacterial Infections; Humans; Infusions, Parenteral; Injections, Intramuscular; Injections, Intravenous; Lactams; Pneumonia; Urinary Tract Infections	2002
Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections. Diagnostic microbiology and infectious disease, 2002, Volume: 43, Issue:2 Topics: Aerobiosis; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lactams; Microbial Sensitivity Tests; Skin Diseases, Bacterial	2002
A beta-lactamase-overproducing strain of Alcaligenes denitrificans subsp. xylosoxydans isolated from a case of meningitis. The Journal of antimicrobial chemotherapy, 1992, Volume: 30, Issue:6 Topics: Adult; Alcaligenes; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Female; Gram-Negative Bacterial Infections; Humans; Meningitis, Bacterial; Microbial Sensitivity Tests; Plasmids	1992